Skip to main content
An official website of the United States government
Español
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

Rylaze

(RY-layz)
A drug that is a recombinant form of asparaginase Erwinia chrysanthemi and is used with other drugs to treat adults and children aged 1 month or older with acute lymphoblastic leukemia or lymphoblastic lymphoma. It is used in people who cannot take the enzyme asparaginase that comes from the bacterium E. coli. Rylaze breaks down the amino acid asparagine and may stop the growth of cancer cells that need asparagine to grow. It may also kill cancer cells. Rylaze is a type of protein synthesis inhibitor.
More Information
Search NCI's Dictionary of Cancer Terms